Begin With the End in Mind: Top 5 Considerations on Your Critical Path to First-in-Human Clinical Trials

You have been moving steadily from discovery into preclinical, and based on the data, your molecule will be advancing into First-in-Human clinical trials. Congratulations are in order ─ but with limited funds, tight resources, and a myriad of conflicting priorities, how do you begin to make sure your organization is ready
for clinical trials?

To help you prioritize what is most important, we have summarized the top five most important considerations on your critical path to FIH clinical trials.